Biomarin Pharmaceutical Inc. Earnings

Biomarin Pharmaceutical Inc.’s revenue jumped 15.65% since last year same period to $747.31Mn in the Q4 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 0.21% jump in its revenue since last 3-months.

Biomarin Pharmaceutical Inc.’s net profit jumped 513.22% since last year same period to $124.94Mn in the Q4 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 17.78% jump in its net profits since last 3-months.

Biomarin Pharmaceutical Inc.’s net profit margin jumped 430.25% since last year same period to 16.72% in the Q4 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 17.53% jump in its net profit margins since last 3-months.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.65 - a -11.77% fall from last quarter’s estimates.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at 0.65.

Biomarin Pharmaceutical Inc.’s earning per share (EPS) jumped 411.11% since last year same period to 0.92 in the Q4 2024. This indicates that the Biomarin Pharmaceutical Inc. has generated 411.11% annual rate of jump in its earning per share (EPS) in the last 4 quarters.